Finch Therapeutics Group Inc (FNCH)
2.24
-0.06
(-2.61%)
USD |
NASDAQ |
Apr 30, 16:00
2.35
+0.11
(+4.91%)
After-Hours: 20:00
Finch Therapeutics Group Total Liabilities (Quarterly): 32.49M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 32.49M |
| September 30, 2023 | 33.68M |
| June 30, 2023 | 38.96M |
| March 31, 2023 | 46.09M |
| December 31, 2022 | 67.23M |
| September 30, 2022 | 67.10M |
| June 30, 2022 | 69.21M |
| Date | Value |
|---|---|
| March 31, 2022 | 24.84M |
| December 31, 2021 | 23.14M |
| September 30, 2021 | 13.18M |
| June 30, 2021 | 22.14M |
| March 31, 2021 | 26.49M |
| December 31, 2020 | 261.06M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
13.18M
Minimum
Sep 2021
261.06M
Maximum
Dec 2020
55.82M
Average
33.68M
Median
Sep 2023
Total Liabilities (Quarterly) Benchmarks
| ACADIA Pharmaceuticals Inc | 317.20M |
| Vanda Pharmaceuticals Inc | 103.53M |
| Sage Therapeutics Inc | 61.80M |
| BioSig Technologies Inc | 4.685M |
| Palisade Bio Inc | 2.739M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 55.37M |
| Shareholders Equity (Quarterly) | 22.89M |